Inflammatory Bowel Disease Center
This is an exciting time in the field of inflammatory bowel disease (IBD). Research advances in the fields of genetics and immunology have rendered a better understanding of the disease and offer hope to one day find a cure.
The University of Pittsburgh Medical Center’s Inflammatory Bowel Disease Center provides specialized care for patients with ulcerative colitis and Crohn’s disease, contributes to the advancement of IBD research, and educates patients and healthcare professionals about IBD. The IBD Center is one of the largest in the nation, with a cohesive team of gastroenterologists and surgeons who are recognized as international experts in their respective specialties.
Directed by gastroenterologists who unite surgeons, nutritionists, radiologists, mental health specialists, and pathologists, the Center is designed provide care for the region’s significant population of patients with IBD. In addition to providing comprehensive primary care to these patients, the Center emphasizes cancer surveillance, women’s health, intestinal rehabilitation and transplantation medicine, psychosocial health and the transition of care from the pediatric to adult gastroenterologist. To maintain the highest possible standards for these specializations in the context of IBD, the Center has partnered with the Pittsburgh Cancer Institute, Magee Women’s Hospital, the Thomas E. Starzl Transplantation Institute, Western Psychiatric Institute and Clinic and Children’s Hospital. By coordinating care across a range of specialties, the Center can provide IBD patients with “one stop shopping” for expert consultations and excellent diagnostic techniques. Thanks to this integrated approach, the IBD Center continues to attract increasingly larger numbers of patients from throughout the U.S.
Pioneering a Subspecialty Medical Home
The UPMC IBD Center is the first program in the U.S. to implement a subspecialty medical home for enhanced patient care. The Total Care-IBD program is a patient’s one stop for comprehensive IBD, nutrition, and psychosocial and stress relief support.
Clinical and Translational Research
The UPMC IBD Center and complementary IBD research initiatives at the University of Pittsburgh School of Medicine make an ongoing commitment to advancing patient care, improving quality of life, and enhancing the psychosocial function in our IBD patients. The UPMC IBD Center routinely cares for some of the most challenging IBD patients in the U.S., with care supported by a top research institution (ranked fourth in NIH funding, 2019).
- One of six centers in the USA and Canada selected for the National Institutes of Health (NIH)/National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) IBD Genetics Consortium.
- Honored as a Vanguard Clinical Site for the Crohn’s & Colitis Foundation’s Study of a Prospective Adult Research Cohort with IBD (SPARC IBD), a cohort of the CCF’s IBD Plexus research initiative. Faculty member, Richard H. Duerr, MD, serves as the associate chief scientist for translational research for the IBD Plexus program.
- The IBD Center identifies patients who have not responded to traditional therapies and recommends these patients for Phase I and II pharmaceutical trials. The IBD Center has been involved in most major clinical studies of new compounds.
- One of a select group of IBD programs to host a Crohn’s & Colitis Foundation of American (CCFA) fellowship and preceptor. These rotations provide physician exposure to IBD in a tertiary referral center and are unique opportunities for gastroenterology fellows and community practitioners.
- “Big data” and a prospective registry with more than two decades of patient enrollment have led to a unique understanding of the natural course of IBD with significant outcomes research.
- Collaboration with the UPMC Health Plan provides a payer-provider relationship focused on improving quality and reducing cost while growing patient-centered research.
The IBD Center team is made up of more than 30 physicians, other healthcare providers, and support personnel working together to provide the highest standard of IBD care.
Inflammatory Bowel Disease Center Co-Directors
|David G. Binion, MD – Head, IBD Translational Research Program
Richard H. Duerr, MD – IBD Genetics Research Chair
Marc B. Schwartz, MD – IBD Clinical Medical Director
IBD Gastroenterologists and Advanced Practice Providers
|Caroline Culig, PA-C
Jill Dusak, PA-C
Gina Kozak, PA-C
Rebecca Lutheran, DNP FNP-C
Cassie Myers, CRNP
|Therezia Alchoufete, MS, RD, LDN
Elyse R. Johnston, MD
Marc Schwartz, MD
Eva M. Szigethy, MD PhD
Emily Weaver, LCSW
|James P. Celebrezze, MD
Kellie Cunningham, MD
Jennifer Holder-Murray, MD
|Kenneth Lee, MD
David S. Medich, MD
Andrew R. Watson, MD, MLitt